Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol
Khaled, Najib Ben, Seidensticker, Max, Ricke, Jens, Mayerle, Julia, Oehrle, Bettina, Rössler, Daniel, Teupser, Daniel, Ehmer, Ursula, Bitzer, Michael
, Waldschmidt, Dirk, Fuchs, Martin, Reuken, Philipp A., Lange, Christian M., Wege, Henning, Kandulski, Arne, Dechene, Alexander, Venerito, Marino, Berres, Marie-Luise, Luedde, Tom
, Kubisch, Ilja, Reiter, Florian P. and De Toni, Enrico N.
(2022)
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol.
Future Oncology 18 (12), pp. 1423-1435.
Date of publication of this fulltext: 29 Feb 2024 13:02
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Future Oncology | ||||
| Publisher: | FUTURE MEDICINE LTD | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 18 | ||||
| Number of Issue or Book Chapter: | 12 | ||||
| Page Range: | pp. 1423-1435 | ||||
| Date | 2022 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin I | ||||
| Identification Number |
| ||||
| Keywords | atezolizumab; BCLC B; bevacizumab; hepatocellular carcinoma; immunotherapy; liver cancer; PD-L1; transarterial chemoembolization; VEGF | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Partially | ||||
| Item ID | 57732 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric